Page 1072 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

Chapter 69

REFERENCES

1. Kaposi’s sarcoma and Pneumocystis pneumonia among homo- 15. Epidemiology of HIV/AIDS—United States, 1981-2005.
sexual men—New York City and California. MMWR Morb MMWR Morb Mortal Wkly Rep. 2006;55:589-592.
Mortal Wkly Rep. 1981;30:305-308. 16. Hall HI, Hughes D, Dean HD, Mermin JH, Fenton KA. HIV
2. Pneumocystis pneumonia—Los Angeles. MMWR Morb Mortal Infection - United States, 2005 and 2008. MMWR Surveill
Wkly Rep. 1981;30:250-252. Summ. 2011;60(suppl):87-89.
3. Hogg RS, Heath KV, Yip B, et al. Improved survival among 17. Pantaleo G, Graziosi C, Fauci AS. New concepts in the immu-
HIV-infected individuals following initiation of antiretroviral nopathogenesis of human immunodeficiency virus infection.
therapy. JAMA. 1998;279:450-454. N Engl J Med. 1993;328:327-335.
4. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining mor- 18. Furtado MR, Callaway DS, Phair JP, et al. Persistence of
bidity and mortality among patients with advanced human HIV-1 transcription in peripheral-blood mononuclear cells in
immunodeficiency virus infection. HIV Outpatient Study patients receiving potent antiretroviral therapy. N Engl J Med.
Investigators. N Engl J Med. 1998;338:853-860. 1999;340:1614-1622.
5. Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with 19. McGovern BH, Golan Y, Lopez M, et al. The impact of cirrhosis
and without HIV infection in Denmark, 1995-2005. Ann Intern on CD4+ T cell counts in HIV-seronegative patients. Clin Infect
Med. 2007;146:87-95. Dis. 2007;44:431-437.
6. Nakagawa F, Lodwick RK, Smith CJ, et al. Projected life expec- 20. Hull MW, Rollet K, Odueyungbo A, et al. Factors associated
tancy of people with HIV according to timing of diagnosis. with discordance between absolute CD4 cell count and CD4
AIDS. 2012;26:335-343. percentage in HIV/hepatitis C coinfected patients. Clin Infect
Dis. 2012;54(12):1798-1805.
7. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD.
The increasing burden of mortality from viral hepatitis 21. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and
in the United States between 1999 and 2007. Ann Intern Med. CD4+ lymphocytes as prognostic markers of HIV-1 infection.
2012;156:271-278. Ann Intern Med. 1997;126:946-954.
8. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two 22. Kahn JO, Walker BD. Acute human immunodeficiency virus
years of providing antiretroviral treatment in Khayelitsha, South type 1 infection. N Engl J Med. 1998;339:33-39.
Africa. AIDS. 2004;18:887-895. 23. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is
active and progressive in lymphoid tissue during the clinically
9. Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral
therapy at primary care sites in Zambia: feasibility and early latent stage of disease. Nature. 1993;362:355-358.
outcomes. JAMA. 2006;296:782-793. 24. Panel on Antiretroviral Guidelines for Adults and Adolescents.
Guidelines for the use of antiretroviral agents in HIV-1-infected
10. Weidle PJ, Malamba S, Mwebaze R, et al. Assessment of a pilot adults and adolescents. Department of Health and Human
antiretroviral drug therapy programme in Uganda: patients’ Services. February 12, 2013; 1-166. http://www.aidsinfo.nih.gov/
response, survival, and drug resistance. Lancet. 2002;360:34-40.
ContentFiles/AdultandAdolescentGL.pdf. Accessed July 16, 2013.
11. Madec Y, Laureillard D, Pinoges L, et al. Response to highly active 25. Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of
antiretroviral therapy among severely immuno-compromised adult HIV infection: 2012 recommendations of the International
HIV-infected patients in Cambodia. AIDS. 2007;21:351-359.
Antiviral Society-USA panel. JAMA. 2012;308:387-402.
12. Zhou J, Kumarasamy N, Ditangco R, et al. The TREAT Asia 26. Williams I, Churchill D, Anderson J, et al. British HIV Association
HIV Observational Database: baseline and retrospective data. guidelines for the treatment of HIV-1-positive adults with anti-
J Acquir Immune Defic Syndr. 2005;38:174-179. retroviral therapy 2012. HIV Med. 2012;13(suppl 2):1-85.
13. UNAIDS/WHO. Global HIV/AIDS Response. Epidemic update 27. Clumeck N, d’Arminio Monforte A, Arribas JR, et al. European
and health sector progess towards Universal Access 2011. http:// AIDS Clinical Society. Guidelines: clinical management and
www.unaids.org/en/media/unaids/contentassets/documents/ treatment of HIV-infected adults in Europe. Version 6-1.
unaidspublication/2011/20111130_ua_report_en.pdf November 2012. http://www.europeanaidsclinicalsociety.org/
14. HIV surveillance—United States, 1981-2008. MMWR Morb images/stories/EACS-Pdf/EacsGuidelines-v6.1-2edition.pdf
Mortal Wkly Rep. 2011;60:689-693. Accessed July 16, 2013.

Section05-O-ref.indd 1 1/20/2015 4:51:21 PM